Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury
Article
Moreno-Vinasco, L, Quijada, H, Sammani, S et al. (2014). Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury
. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 51(2), 223-228. 10.1165/rcmb.2012-0519OC
Moreno-Vinasco, L, Quijada, H, Sammani, S et al. (2014). Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury
. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 51(2), 223-228. 10.1165/rcmb.2012-0519OC